FindTrial
Sign In

General Anesthesia For obese patients

Study of the Safety and the Efficacy of Rocuronium versus Cisatracurium for Rapid Sequence Induction of Anaesthesia in Morbidly Obese Patient: A comparative Randomized study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201703002147145
Enrollment
Unknown
Registered
2017-03-26
Start date
2017-03-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid obesity

Interventions

Rocuronium group (ROC)
Cisatracurium group (CIS)

Sponsors

Tanta University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: physical status ASAII&III age 20-40 BMI 40-50 kg/m2 scheduled for elective surgery

Exclusion criteria

Exclusion criteria: Patient refusal to participate in research. Patients having major hepatic, renal, cardiovascular, pulmonary and neuromuscular diseases. Pregnant patients. Supermorbidant obese patient with BMI <50kg/m2. Known or suspected allergy to used drugs Patients who should be offered awake intubation.

Design outcomes

Primary

MeasureTime frame
Quality of relaxation of both drugs—

Secondary

MeasureTime frame
Safety of both drugs (Heart rate, Mean arterial pressure)—

Countries

Egypt

Contacts

Public ContactFatheya Khairy

Employer at ministry of health

Fatheya.khairy343l@gmail.com00201222613077

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026